Researchers Develop SARS-CoV-2 Neutralizing Antibody that Could Cure as Well as Prevent COVID-19
A team of Chinese researchers have successfully identified multiple highly potent neutralizing antibodies against the novel coronavirus SARS-CoV-2 from convalescent plasma by using high-throughput single-cell sequencing. More...21 May 2020
New COVID-19 Vaccine Candidate Uses Existing Deactivated Rabies Vaccine as Vehicle for Coronavirus Proteins
Thomas Jefferson University (Philadelphia, PA, USA) has signed an exclusive deal with vaccine innovator Bharat Biotech International (Hyderabad, India) to develop a new vaccine candidate for COVID-19 invented at Jefferson. More...21 May 2020
CDC Plans Massive COVID-19 Antibody Study to Understand Spread of SARS-CoV-2 Virus
In order to learn more about how many people have been infected with SARS-CoV-2 and how it is spreading through the US population, the US Centers for Disease Control and Prevention {(CDC) Atlanta, GA, USA} plans to conduct a huge national serology test. More...20 May 2020
Johnson & Johnson Partners with Vibalogics on Development of Lead COVID-19 Vaccine Candidate
Vibalogics GmbH (Cuxhaven, Germany) will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by Johnson & Johnson’s (New Brunswick, NJ, USA) Janssen Pharmaceutical Companies (Beerse, Belgium). More...20 May 2020
PharmaJet and Abnova to Jointly Develop and Deliver COVID-19 mRNA Vaccine Using Needle-Free Injection Technology
PharmaJet’s (Golden, CO, USA) Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2 that is being developed by Abnova Corporation (Taipei, Taiwan). More...20 May 2020
Quidel Granted FDA EUA for Lyra Direct SARS-CoV-2 Assay to Allow Direct Sample Processing
Quidel Corporation (San Diego, CA, USA) has received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2 Assay from the Food and Drug Administration (FDA) to allow direct sample processing. More...20 May 2020
Gold Member
12-Channel ECG
CM1200B
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Cannulating Sphincterotome
TRUEtome
New
Anterior Cervical Plate System
XTEND
In Other News
Ortho's COVID-19 IgG Antibody Test Receives CE Mark
DxGen Launches '2 Minutes' COVID-19 Antibody Testing System
Bio-Rad’s CFX96 Dx Real-Time PCR System Listed with FDA for IVD Testing
Technopath Launches Multichem ID-COVID-19 Quality Control Solutions
New COVID-19 Antibody Test Platform Combines Antibody Testing and Blockchain Technology
Stanford Researchers Investigate New Drug that Can Treat Mild COVID-19 Cases and Stem Viral Shedding
Philips Receives FDA Clearance for Use of Ultrasound Portfolio to Manage COVID-19 Complications
Moderna Announces Positive Interim Phase 1 Data for mRNA-1273 Coronavirus Vaccine
COVID-19 Patients Face Higher Risk of Dangerous Blood Clots
MicroRNA ‘Nose Cocktail’ Could Help Fight COVID-19
New COVID-19 Mouth Swab Test Can Be Completed On-Premises in 13-25 Minutes Without Laboratory Involvement
Beckman Coulter-BARDA Partnership Expanded for Sepsis Diagnostic and Prediction Algorithm in COVID-19 Patients
Critically Ill COVID-19 Patients Improve Significantly After Receiving Experimental Heart Cell Therapy
Self-Assembling Nanoparticle Technology Could Be Game Changer for COVID-19 Vaccine Development
Oxford University's Coronavirus Vaccine Shows Very Encouraging Results in Tests on Monkeys
Breakthrough Coronavirus Antibody Drug Could Cure COVID-19
World’s First SARS-CoV-2 Serology Test Detects Neutralizing Antibodies Without Containment Facility or Specimen
Hologic’s Second Molecular Test for COVID-19 Granted FDA Emergency Use Authorization
Roche Launches New Blood Gas Digital Solution for Diagnosis of COVID-19 Patients with Respiratory Compromise
FDA Requires Real Patient Samples for Emergency Use Authorization of COVID-19 MDx Tests
More than One Effective Vaccine Required to Protect Global Community from SARS-CoV-2, Says NHI
Researchers Identify Twin Antibodies that Block Coronavirus from Entering Human Cells
Neovii and Tel Aviv University to Jointly Develop Novel COVID-19 Vaccine
